Burçin Çakan Demirel

17PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Clinical midwiferyNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 25, 2026
Circadian timing of first-line chemoimmunotherapy is associated with survival in extensive-stage small cell lung cancer.

|Aug 27, 2026
Prognostic Significance and Clinical Implications of the New FIGO 2023 Staging System in Patients with Endometrial Cancer.

|Aug 27, 2026
Comparative Prognostic Value of Systemic Inflammation-Based Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with First-Line Immunotherapy.

|Aug 27, 2026
Radiotracer-Free Axillary Staging with ICG and Methylene Blue After Neoadjuvant Chemotherapy: Does Failure to Retrieve the Clipped Node Matter?

|Jul 15, 2026
Association of Pretreatment Immune-Inflammatory Biomarkers with Pathological Tumor Regression Following Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

|May 04, 2026
Combined Lung Immune Prognostic Index (LIPI)-Glasgow Prognostic Score (GPS) as a Prognostic Tool in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy.

Pageof 3

Frequent Collaborators

6 joint publications

Ahmet Bilici

6 joint publications

Erdem Sunger

5 joint publications

Şahin Bedir

5 joint publications

Jamshid Hamdard